Department of Anesthesiology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Organ Transplant Center, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Organogenesis. 2024 Dec 31;20(1):2386730. doi: 10.1080/15476278.2024.2386730. Epub 2024 Aug 4.
Post-reperfusion syndrome (PRS) is a severe and highly lethal syndrome that occurs after declamping the portal vein forceps during liver transplantation. It is marked by severe hemodynamic disturbances manifested by decreased mean arterial pressure, increased heart rate and elevated pulmonary artery pressure. The complex pathogenesis of PRS remains understudied. It is generally believed to be related to the large amount of acidic, cold blood that enters the circulation after release of the portal clamp. This blood is rich in oxygen-free radicals and metabolic toxins, which not only aggravate the ischemia-reperfusion injury of the liver but also further attack the systemic organs indiscriminately. Considering the range of possible adverse prognoses including acute kidney injury, delirium and graft nonfunction, it is imperative that clinicians increase their awareness and prevention of PRS. The aim of this article is to review the current risk factors, pathophysiological mechanisms and prevention strategies for PRS.
再灌注后综合征(PRS)是肝移植时松开门脉阻断钳后发生的一种严重且致命性极高的综合征。其特征为严重的血流动力学紊乱,表现为平均动脉压降低、心率增快和肺动脉压升高。PRS 的复杂发病机制仍研究不足。一般认为与门脉夹松开后大量酸性、低温血液进入循环有关。该血液富含氧自由基和代谢毒素,不仅加重肝脏的缺血再灌注损伤,还会无差别地进一步攻击全身器官。考虑到包括急性肾损伤、谵妄和移植物功能丧失在内的可能不良预后范围,临床医生必须提高对 PRS 的认识和预防。本文旨在综述 PRS 的目前危险因素、病理生理机制和预防策略。